Fumihiko Inoue
- Co-authors
- Hisato KobayashiShuji SekoOsamu NishidaTatsuyoshi SaigaMinoru S.H. KoTatsuo FukuseTomoki TaniguchiMasaki Okamoto
- Topics
- IgG4-Related and Inflammatory Diseases (5 papers)Pancreatitis Pathology and Treatment (5 papers)Gastrointestinal disorders and treatments (4 papers)
- Partner nations
- JapanUnited Kingdom
In The Last Decade
Fumihiko Inoue
28 papers receiving 518 citations
Peers
Comparison fields: 5 of 59
- Surgery 297
- Rheumatology 211
- Epidemiology 135
- Immunology 87
- Pulmonary and Respiratory Medicine 82
Countries citing papers authored by Fumihiko Inoue
This map shows the geographic impact of Fumihiko Inoue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumihiko Inoue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumihiko Inoue more than expected).
Fields of papers citing papers by Fumihiko Inoue
This network shows the impact of papers produced by Fumihiko Inoue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumihiko Inoue. The network helps show where Fumihiko Inoue may publish in the future.
Co-authorship network of co-authors of Fumihiko Inoue
This figure shows the co-authorship network connecting the top 25 collaborators of Fumihiko Inoue. A scholar is included among the top collaborators of Fumihiko Inoue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumihiko Inoue. Fumihiko Inoue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 19 | |
| 3 | 22 | |
| 4 | 18 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 3 | |
| 8 | 25 | |
| 9 | 21 | |
| 10 | 55 | |
| 11 | 21 | |
| 12 | 10 | |
| 13 | 39 | |
| 14 | Low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor (CAG regimen) for previously treated patients with relapsed or primary resistant acute myelogenous leukemia (AML) and previously untreated elderly patients with AML, secondary AML, and refractory anemia with excess blasts in transformation. | 58 |
| 15 | Intraperitoneal administration of ascorbic acid delays the turnover of 3H-labelled cortisol in the plasma of an ODS rat, but not in the Wistar rat. Evidence in support of the cardinal role of vitamin C in the progression of glucocorticoid synthesis. | 2 |
| 16 | 19 | |
| 17 | 0 | |
| 18 | [Hepatocellular carcinoma in patient with primary biliary cirrhosis]. | 1 |
| 19 | 12 | |
| 20 | 1 |
About Fumihiko Inoue
Fumihiko Inoue is a scholar working on Hematology, Surgery and Rheumatology, having authored 30 papers that have together received 544 indexed citations. Recurring topics across this work include IgG4-Related and Inflammatory Diseases (5 papers), Pancreatitis Pathology and Treatment (5 papers) and Gastrointestinal disorders and treatments (4 papers). The work is most often cited by research in Rheumatology (211 citations), Transplantation (23 citations) and Hematology (75 citations). Fumihiko Inoue has collaborated with scholars based in Japan and United Kingdom. Frequent co-authors include Hisato Kobayashi, Shuji Seko, Osamu Nishida, Tatsuyoshi Saiga, Minoru S.H. Ko, Tatsuo Fukuse, Tomoki Taniguchi, Masaki Okamoto, Masaki Kitajima and Osamu Aramaki. Their work appears in journals such as Transplantation, Journal of Clinical Pathology and World Journal of Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.